Delivery Order SPE2DB22D2009-SPE2DB24FL9UH

Award Date 5/20/24
Potential Completion Date 5/21/24
Potential Value $229K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is a delivery order valued at $30,442.50 for the supply of the pharmaceutical product MENVEO 1 VIAL-A-C-Y-W-135-DIP 0.5ML. The contract has an ultimate completion date of June 13, 2024 and was awarded on June 12, 2024 by the Defense Logistics Agency (DLA), a defense agency. Amerisourcebergen, a major pharmaceutical distribution company, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division provides for the delivery of MENVEO 1 VIAL-A-C-Y-W-135-DIP 0.5ML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The single-award Indefinite Delivery Contract (IDC) with DLA Troop Support Medical is valued up to $999,999,999.00 through December 31, 2025, and serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical supplies...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is a delivery order valued at $9,346.66 for the supply of MENVEO 1 VIAL-A-C-Y-W-135-DIP 0.5ML pharmaceutical products. The award was issued by the Defense Logistics Agency (DLA), a defense agency, on July 12, 2024, with a completion date of July 15, 2024. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division for the delivery of the pharmaceutical product MENVEO 1 VIAL-A-C-Y-W-135-DIP 0.5ML. The firm fixed-price delivery order has a ceiling value of $5,030.65 and a completion date of May 13, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued up to...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of MENVEO 1 VIAL-A-C-Y-W-135-DIP 0.5ML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $6,088.50 firm fixed price delivery order has a completion date of June 13, 2024. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical as the primary vehicle for delivering a range of pharmaceutical products and medical...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of MENVEO 1 VIAL-A-C-Y-W-135-DIP 0.5ML pharmaceutical products to the Defense Logistics Agency (DLA). The Delivery Order, valued at $30,442.50, was issued under an Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, which has a maximum potential value of $999,999,999.00 through December 31, 2025. This single-award IDC serves as the primary...
This federal contract award, valued at $6,153.90, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is a delivery order for MENVEO 1 VIAL-A-C-Y-W-135-DIP 0.5ML, a pharmaceutical product. Amerisourcebergen, a major pharmaceutical distribution company, holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical worth up to $999,999,999.00 through December 2025. This single-award IDC serves as the...
This federal contract award, valued at $2,211.18, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of 4564882158 - MENVEO 1 VIAL-A-C-Y-W-135-DIP 0.5ML, a pharmaceutical product. The contract is a firm-fixed price Delivery Order with a completion date of June 12, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation's Corporate Office Division, a major pharmaceutical supplier to the U.S. government. The $5,189.11 firm fixed-price delivery order is for the supply of MENVEO 1 VIAL-A-C-Y-W-135-DIP 0.5ML, a vaccination product. The contract has an ultimate completion date of April 23, 2024. Amerisourcebergen also holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is a Delivery Order valued at $18,265.50 for the supply of MENVEO 1 VIAL-A-C-Y-W-135-DIP 0.5ML, a pharmaceutical product. The contract was awarded by the Defense Logistics Agency (DLA), a major defense agency, and does not have a set-aside designation. Amerisourcebergen is a leading pharmaceutical distributor that has been awarded multiple Indefinite Delivery Contracts (IDCs) by federal agencies, including...
  • SPE2DB22D2009
    Indefinite Delivery Contract
  • SPE2DB22D2009-SPE2DB24FL9UH
    Delivery Order

This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is a delivery order worth $229,017.14 for the supply of a pharmaceutical product called MENVEO 1 VIAL-A-C-Y-W-135-DIP 0.5ML. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of May 21, 2024. It is a firm fixed-price contract with no set-aside designation.

Amerisourcebergen, a major pharmaceutical distribution company, is the prime contractor and holds a large Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. This IDC serves as the primary vehicle for Amerisourcebergen to deliver a wide range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense globally. The company also holds a smaller IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs, valued up to $750,000 through May 2024.

Generated 8/25/24, 12:15 AM